Skip to Content

INSITE: Investigation of Sacroiliac Fusion Treatment


Investigation of Sacroiliac Fusion Treatment is a multicenter, prospective, randomized trial. Patients with the two conditions for which iFuse is indicated (degenerative sacroiliitis and sacroiliac joint disruption) are enrolled if they meet eligiblity all criteria and agree to participate in the study. Patients are randomized to either immediate iFuse treatment or an optimized program of non-surgical management (NSM).

For more information:

Overlake Medical Clinics Neurosurgery

Principal Investigator(s)
Abhineet Chowdhary, MD

Clinical Trial Categories

  • Neurosurgery
Tina Fortney, RN, CCRC at 425-688-5407


  • Overlake Hospital Medical Center
    1035 116th Ave. NE
    Bellevue, WA 98004
    Main: 425-688-5000